MENU

Quintis Ltd shares: Avoid at all costs

Embattled sandalwood grower Quintis Ltd (ASX: QIN) updated the market yesterday. The company has slashed its sales guidance and withdrew its previous earnings guidance.

Curiously, this announcement was not marked as market sensitive, although I bet that shareholders would beg to differ. Here’s what management had to say:

  • The Company is unable to accurately predict the outcome of the coming sales season and so the Company is withdrawing its Cash EBITDA guidance for the year to 30 June 2017.
  • The Company now anticipates product sales in the range of $25m to $35m (down from $45m to $55m previously)
  • As at 31 May 2017, the Company’s cash and cash equivalents were $17m… The Company is in on-going discussions with a number of parties with the aim of finalising a recapitalisation of the business.
  • Quintis has received non-binding equity and debt propositions from multiple parties. Discussions are on-going and no binding offer may eventuate, so Quintis has requested that its shares be kept suspended.

It’s an unfortunate evolution in the saga that has smashed the value of the company’s shares down 78% in a year. While the above statements speak clearly to the business’ troubles, they’re not the only issues that have been raised.

Management was not aware that a contract with Galderma (a key customer) has been cancelled for more than 4 months after the cancellation agreement had been signed. The Managing Director Frank Wilson also departed with zero warning 2 months ago, just before the problems with earnings became apparent.

Given all of the red flags and the additional issues revealed in yesterday’s announcement, I would avoid Quintis at all costs. Even if you took the view that shares are undervalued today – and I think this would be an extremely risky view to take – the possibility of a recapitalisation could see the value of your shares vanishing.

Forget about Quintis, and check out these 3 reliable dividend payers instead:

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

HOT OFF THE PRESSES: My #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.